Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

3.0K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
3.0K
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

393
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
393
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence01:19

Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

83
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
83
Effects of Chemicals: Overview01:27

Effects of Chemicals: Overview

1.8K
Drugs, encompassing various chemical compounds from natural sources, lab synthesis, or genetic engineering, elicit different biological responses in living organisms. Some of these responses are desirable or therapeutic, while others are undesirable. The primary goal of administering a drug is to achieve a therapeutic effect, that is, to address a specific disease or health condition. Any concurrent effects outside of this therapeutic outcome are considered undesirable. These undesirable...
1.8K
Biopharmaceutical Factors Influencing Drug Product Design: Overview01:22

Biopharmaceutical Factors Influencing Drug Product Design: Overview

118
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
118
Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

3.4K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Green pharmacy practice: a cross-sectional study to evaluate awareness and application within community pharmacy.

The International journal of pharmacy practice·2026
Same author

Physicochemical characterisation of difluprednate and 6α9α-difluoroprednisolone: Determination of solubility, pKa and LogP.

Steroids·2026
Same author

CYP2C19 genetic polymorphisms and proton pump inhibitor therapy resistance in patients with gastrooesophageal reflux disease: a preliminary observational cohort study.

Drug metabolism and personalized therapy·2026
Same author

Usability evaluation of standard operating procedures for extended community pharmacy services.

The International journal of pharmacy practice·2026
Same author

medicX-KG: a knowledge graph for pharmacists' drug information needs.

Journal of biomedical semantics·2025
Same author

Implementation of a pharmaceutical care model within paediatric oncology.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2025
Same journal

Corrigendum to "2D:4D ratio, affective lability, and impulsivity in men with cannabinoid and methamphetamine use disorders: A comparative analysis with healthy controls" [Early Hum. Dev. Volume 221:106587(2026)].

Early human development·2026
Same journal

Risk factors associated with the development of metabolic bone disease in infants admitted to the pediatric intensive care unit.

Early human development·2026
Same journal

Association of cardiac perfusion index with cerebral regional oxygen saturation and fractional tissue oxygen extraction in preterm infants.

Early human development·2026
Same journal

Long-term motor outcomes after parent-administered early physiotherapy in children born very preterm.

Early human development·2026
Same journal

Second-to-fourth digit ratio in polycythemia vera: An exploratory anthropometric comparison with secondary polycythemia and healthy controls.

Early human development·2026
Same journal

Infants who crawl while skin-to-skin in the first hour after birth are more likely to effectively breastfeed postpartum.

Early human development·2026
See all related articles

Related Experiment Video

Updated: Dec 5, 2025

Identification of Pharmaceuticals in The Aquatic Environment Using HPLC-ESI-Q-TOF-MS and Elimination of Erythromycin Through Photo-Induced Degradation
05:46

Identification of Pharmaceuticals in The Aquatic Environment Using HPLC-ESI-Q-TOF-MS and Elimination of Erythromycin Through Photo-Induced Degradation

Published on: August 1, 2018

13.4K

Pharmaceuticals and the environment.

Nicolette Sammut Bartolo1, Lilian M Azzopardi1, Anthony Serracino-Inglott1

  • 1Department of Pharmacy, Faculty of Medicine and Surgery, University of Malta, Msida, Malta.

Early Human Development
|October 17, 2020
PubMed
Summary
This summary is machine-generated.

Pharmaceuticals impact the environment, affecting ecosystems. Implementing green practices in pharmacy, from manufacturing to patient disposal, mitigates this environmental footprint and reduces pollution.

Keywords:
Carbon footprintEducationEnvironmental impactGreen practicesPharmaceuticalsWaste prevention

More Related Videos

Collection of Alfalfa Root Exudates to Study the Impact of Di2-ethylhexyl Phthalate on Metabolite Production
06:46

Collection of Alfalfa Root Exudates to Study the Impact of Di2-ethylhexyl Phthalate on Metabolite Production

Published on: June 2, 2023

2.1K
Elucidating the Metabolism of 2,4-Dibromophenol in Plants
06:54

Elucidating the Metabolism of 2,4-Dibromophenol in Plants

Published on: February 10, 2023

1.4K

Related Experiment Videos

Last Updated: Dec 5, 2025

Identification of Pharmaceuticals in The Aquatic Environment Using HPLC-ESI-Q-TOF-MS and Elimination of Erythromycin Through Photo-Induced Degradation
05:46

Identification of Pharmaceuticals in The Aquatic Environment Using HPLC-ESI-Q-TOF-MS and Elimination of Erythromycin Through Photo-Induced Degradation

Published on: August 1, 2018

13.4K
Collection of Alfalfa Root Exudates to Study the Impact of Di2-ethylhexyl Phthalate on Metabolite Production
06:46

Collection of Alfalfa Root Exudates to Study the Impact of Di2-ethylhexyl Phthalate on Metabolite Production

Published on: June 2, 2023

2.1K
Elucidating the Metabolism of 2,4-Dibromophenol in Plants
06:54

Elucidating the Metabolism of 2,4-Dibromophenol in Plants

Published on: February 10, 2023

1.4K

Area of Science:

  • Environmental Science
  • Pharmaceutical Science
  • Ecosystem Health

Background:

  • The increasing availability of pharmaceuticals has led to significant environmental contamination.
  • Pharmaceuticals in both human and veterinary medicine impact terrestrial and marine ecosystems.

Purpose of the Study:

  • To highlight the environmental impact of pharmaceuticals.
  • To explore green practices and measures for mitigating pharmaceutical pollution.
  • To emphasize the role of various stakeholders in promoting environmental sustainability in the pharmaceutical sector.

Main Methods:

  • Review of environmental impacts associated with pharmaceutical consumption.
  • Analysis of green manufacturing principles and alternative processes.
  • Examination of stakeholder roles (distributors, pharmacists, patients) in reducing environmental burden.
  • Assessment of educational strategies for future pharmacists.

Main Results:

  • Green practices in manufacturing and operations reduce environmental impact.
  • Efficient inventory management and waste reduction by distributors and pharmacists are crucial.
  • Integrating environmental consciousness into pharmacy education fosters a proactive workforce.
  • Patient education on medication hoarding and proper disposal is essential.

Conclusions:

  • Adoption of green practices across the pharmaceutical lifecycle minimizes chemical use and waste.
  • Reduced pharmaceutical pollution contributes to mitigating climate change.
  • A collaborative approach involving industry, professionals, and patients is key to environmental protection.